Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-14

Clinical Trial Update: Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating sulpiride vs placebo for reducing hot flashes in menopausal syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulpiride (sulpiride)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Menopausal Syndrome, Hot Flashes | Phase 3 | Status: COMPLETED